Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in La Jolla. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in La Jolla at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
Ficerafusp alfa is directed against two targets, Epidermal Growth Factor Receptor (EGFR) and Transforming Growth Factor beta (TGF-β). This study intends to evaluate the safety and efficacy of ficerafusp alfa in combination with pembrolizumab versus placebo with pembrolizumab in 1L PD-L1-positive, recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC).
Sponsor: Bicara Therapeutics
Check if you qualify for this head and neck cancer clinical trial in La Jolla, CA
If you're searching for head and neck cancer treatment options in La Jolla, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our La Jolla research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.